Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Cilloni

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Journal of Cellular and Molecular Medicine|April 6, 2026
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTACDaniela Cilloni, Alessandro Ferrando, Francesco Frassoni
Methods in Molecular Medicine|March 1, 2006
WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromesDaniela Cilloni, Enrico Gottardi, Giuseppe Saglio
Current Opinion in Drug Discovery & Development|September 3, 2010
Emerging targets for hematological malignanciesDaniela Cilloni, Francesco Frassoni, Giuseppe Saglio
Journal of Clinical Medicine|August 29, 2024
Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A ReviewJohanna Umurungi, Francesca Ferrando, Daniela Cilloni, et al.
International Journal of Molecular Sciences|September 9, 2023
A Leukemic Target with a Thousand Faces: The MitochondriaBeatrice Maffeo, Cristina Panuzzo, Amedeo Moraca, et al.
Cancers|October 14, 2022
<i>SF3B1</i> Mutations in Hematological MalignanciesDaniela Cilloni, Federico Itri, Valentina Bonuomo, et al.
Journal of Clinical Medicine|February 13, 2026
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient MonitoringAlessandro Ferrando, Valentina Bonuomo, Arianna Savi, et al.
Expert Opinion on Emerging Drugs|March 6, 2010
Emerging drugs for chronic myeloid leukemiaDaniela Cilloni, Emanuela Messa, Antonia Rotolo, et al.
Cancer Letters|July 26, 2008
Imatinib resistance in CMLGisella Volpe, Cristina Panuzzo, Stefano Ulisciani, et al.
British Journal of Haematology|May 3, 2019
Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and KusecEmiliano Fabiani, Lia Valentini, Daniela Cilloni, et al.
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Journal of Cellular and Molecular Medicine|April 6, 2026
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTACDaniela Cilloni, Alessandro Ferrando, Francesco Frassoni
Methods in Molecular Medicine|March 1, 2006
WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromesDaniela Cilloni, Enrico Gottardi, Giuseppe Saglio
Current Opinion in Drug Discovery & Development|September 3, 2010
Emerging targets for hematological malignanciesDaniela Cilloni, Francesco Frassoni, Giuseppe Saglio
Journal of Clinical Medicine|August 29, 2024
Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A ReviewJohanna Umurungi, Francesca Ferrando, Daniela Cilloni, et al.
International Journal of Molecular Sciences|September 9, 2023
A Leukemic Target with a Thousand Faces: The MitochondriaBeatrice Maffeo, Cristina Panuzzo, Amedeo Moraca, et al.
Cancers|October 14, 2022
<i>SF3B1</i> Mutations in Hematological MalignanciesDaniela Cilloni, Federico Itri, Valentina Bonuomo, et al.
Journal of Clinical Medicine|February 13, 2026
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient MonitoringAlessandro Ferrando, Valentina Bonuomo, Arianna Savi, et al.
Expert Opinion on Emerging Drugs|March 6, 2010
Emerging drugs for chronic myeloid leukemiaDaniela Cilloni, Emanuela Messa, Antonia Rotolo, et al.
Cancer Letters|July 26, 2008
Imatinib resistance in CMLGisella Volpe, Cristina Panuzzo, Stefano Ulisciani, et al.
British Journal of Haematology|May 3, 2019
Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and KusecEmiliano Fabiani, Lia Valentini, Daniela Cilloni, et al.
Pageof 20